Morphin 10 Retard (Morphine Sulfate)

Morphine sulfate, the active ingredient in Morphin 10 Retard, is an opioid analgesic presented as a 10 mg extended‑release oral tablet for oral use. It treats severe acute pain, cancer pain and post‑operative pain in adult patients.

GNH USA supplies Morphin 10 Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine sulfate is an opioid analgesic used to manage severe pain through central nervous system mu‑opioid receptor activation.

Severe acute pain: provides rapid relief of intense pain episodes. Cancer pain: controls persistent pain associated with malignant disease. Post‑operative pain: manages pain following surgical procedures.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Allergic reactions, including anaphylaxis

Morphin 10 Retard requires careful clinical assessment and monitoring. - Assess pain severity before initiating therapy: ensure opioid indication is appropriate. - Monitor respiratory function: watch for signs of depression, especially after dose changes. - Evaluate for opioid dependence: screen patients with a history of substance use. - Adjust dose in renal or hepatic impairment: consider reduced clearance. - Avoid concurrent CNS depressants when possible: may increase sedation risk. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Morphin 10 Retard may interact with several medicines; clinicians should review patient medication lists. Major Interactions (Avoid): - Concomitant use with other opioids: additive respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates): heightened sedation and respiratory risk. - MAO inhibitors: risk of severe hypotension and serotonin syndrome. Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect. - Anticholinergic agents: can exacerbate constipation.